AUSTRALIAN pharmacists need
to be on the lookout for people
with the symptoms of Chronic
Obstructive Pulmonary Disease
(COPD) this winter, according to the
Australia Lung Foundation.
It is expected that this year
21,000 Australians will be
hospitalised by COPD over the
coming months, whilst many more
will visit their GP as a result of the
condition.
“Pharmacists play a vital role in
identifying people who may be at
risk of Chronic Obstructive
Pulmonary Disease and are ideally
placed to recommend that people
with symptoms see their doctor,”
said Lung Foundation National
Council member Professor
Christine Jenkins.
Pharmacists who would like a
pack of resources, incl information
about COPD screening in pharmacy
should call 1800 654 301.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Jun 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Jun 12
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.